Medicale Corp (NASDAQ: MCLE) cites auditor change for late SEC report

Rhea-AI Filing Summary

Medicale Corp. submitted a Form 12b-25 to notify regulators that it will not file its report for the period ended September 30, 2025 on time. The company explains that it could not complete its financial statements without unreasonable effort or expense because of a recent change in auditor. This filing is a standard mechanism that gives the company a short extension to complete and submit the delayed report.

Insights

Equity & disclosure analyst

Medicale cites an auditor change for a late quarterly filing, a modestly negative disclosure risk-wise.

Medicale Corp. has filed a Form 12b-25 indicating it cannot file its report for the period ended September 30, 2025 on time. The stated reason is that its financial statements could not be completed without unreasonable effort or expense due to a recent change in auditor.

This type of notification is a standard tool that provides a brief extension for filing, but tying the delay to an auditor transition can raise questions about the complexity and timing of the financial reporting process. The text does not describe any expected changes in operating results, so the concern here is procedural rather than about specific numbers.

Subsequent periodic reports from Medicale Corp. will clarify whether the delay remains an isolated timing issue related to the new auditor or is associated with broader reporting challenges.

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 12b-25

NOTIFICATION OF LATE FILING

(Check one): ☒ Form 10-K      ☐ Form 20-F      ☐ Form 11-K      ☐ Form 10-Q      ☐ Form 10-D      ☐ Form N-CEN      ☐ N-CSR

For Period Ended: September 30, 2025

☐ Transition Report on Form 10-K

☐ Transition Report on Form 20-F

☐ Transition Report on Form 11-K

☐ Transition Report on Form 10-Q

For the Transition Period Ended: _______________

Read Instruction (on back page) Before Preparing Form. Please Print or Type.

Nothing in this form shall be construed to imply that the Commission has verified any information contained herein.

If the notification relates to a portion of the filing checked above, identify the item(s) to which the notification relates:

PART I - REGISTRANT INFORMATION

Medicale Corp.

Full Name of Registrant:

N/A

Former Name if Applicable

9314 Forest Hill Blvd #929

Address of Principal Executive Office (Street and Number)

Wellington, FL 33411

City, State, Zip Code

PART II - RULES 12b-25(b) AND (c)

If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate)

	(a)	The reasons described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense;
☒	(b)	The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, 11-K or Form N-CEN or Form N-CSR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report of transition report on Form 10-Q or subject distribution report on Form 10-D, or portion thereof will be filed on or before the fifth calendar day following the prescribed due date; and
	(c)	The accountant's statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.

PART III - NARRATIVE

State below in reasonable detail the reasons why Forms 10-K, 20-F, 11-K, 10-Q, 10-D, N-CEN, N-CSR, or the transition report or portion thereof could not be filed within the prescribed time period.

The Registrant is unable to file the subject report in a timely manner because the Registrant was not able to complete timely its financial statements without unreasonable effort or expense as there was a recent change in auditor.

PART IV - OTHER INFORMATION

(1) Name and telephone number of person to contact in regard to this notification:

ZD CHEN		407		245-7339
(Name)		(Area Code)		(Telephone No.)

(2) Have all other periodic reports required under section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If the answer is no, identify report(s). ☒ Yes ☐ No

(3) Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof? ☐ Yes ☒ No

If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.

2

Medicale, Corp.

(Name of Registrant as Specified in Charter)

has caused this notification to be signed on its behalf by the undersigned thereunto duly authorized.

Date: December 30, 2025 By: /s/      Chen Zu De                   

3

FAQ

What did Medicale Corp. (MCLE) file with the SEC?

Medicale Corp. filed a Form 12b-25, which is a notification of late filing, stating it will not file its report for the period ended September 30, 2025 by the original deadline.

Why is Medicale Corp. delaying its report for the period ended September 30, 2025?

The company states it was unable to complete its financial statements in time without unreasonable effort or expense because there was a recent change in auditor.

Which type of report is affected by Medicale Corp.’s Form 12b-25?

The Form 12b-25 relates to the company’s periodic report for the period ended September 30, 2025, using the standard Form 12b-25 language covering annual and quarterly reports.

Does Medicale Corp. mention auditor issues beyond the timing impact?

The narrative only explains that a recent change in auditor prevented timely completion of the financial statements; it does not describe further auditor-related issues.

What additional questions are included in Medicale Corp.’s Form 12b-25?

The form asks whether all other required periodic reports have been filed and whether any significant change in results of operations is expected in the upcoming report, along with a request for an explanation if so.